
Switzerland · Medical devices startup
Medyria is a Swiss medtech company founded in 2012 that specializes in sensor-based technologies for blood flow velocity (BFV) sensing.
Funding reportedLast round: Series B
Medyria is a Swiss medtech company founded in 2012 that specializes in sensor-based technologies for blood flow velocity (BFV) sensing.
The company focuses on enhancing endovascular catheter navigation and cardiovascular diagnosis. Its mission is to make catheter-based procedures faster, safer, and more effective by providing real-time physiological data during interventional cardiology. The company’s primary product is the PyCath, a stand-alone microcatheter that allows for a comprehensive physiological assessment of the heart through direct BFV measurement. Medyria also offers PyCath Metrics, which delivers real-time data on key coronary indexes, and an OEM sensor for integration into other cardiovascular devices. Medyria serves cardiologists and healthcare professionals, primarily in Switzerland, and aims to improve patient outcomes for those with cardiovascular diseases.
Funding, as reported
What they build
Known for
health caremedical device integrationsensor integration in cathetersreal-time datadistributionmanufacturingmicro sensors in medical devicesblood flow measurementsensor-based microcatheterblood flow velocity measurementcardiologymicro device for cardiologyblood flow velocitymicro sensorsclinical researchhospital & health care
Built with from their website
Google App EngineHREF LangGoogle CloudViewport MetaVarnishwebpackGoogle Cloud HostingAIPriority HintsReact
Microsoft ExchangeSirvoyWix eCommerceMicrosoft 365 Apps & ServicesWebsiteBuilderASP.NETMobile FriendlyLodash
Add your raise, your deck and your story, and put Medyria in front of investors. Or tell us what we have wrong.